Monitoring the Early Response of Fulvestrant Plus Tanshinone IIA Combination Therapy to Estrogen Receptor-Positive Breast Cancer by Longitudinal (18)F-FES PET/CT

Endocrine monotherapy of breast cancers is generally hampered by the primary/acquired resistance and adverse sides in clinical settings. Herein, advantaging the multitargeting antitumor effects and normal organ-protecting roles of Chinese herbal medicine, the aim of this study was to investigate the...

Descripción completa

Detalles Bibliográficos
Autores principales: He, SiMin, Wang, MingWei, Zhang, YongPing, Luo, JianMin, Zhang, YingJian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590558/
https://www.ncbi.nlm.nih.gov/pubmed/31281233
http://dx.doi.org/10.1155/2019/2374565

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590558/
https://www.ncbi.nlm.nih.gov/pubmed/31281233
http://dx.doi.org/10.1155/2019/2374565

Ejemplares similares